Back to Search
TYLER JUNTTILA, MD
MD
Ophthalmology Physician
NPI: 1447772991IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Ophthalmology PhysicianPrimary
Ophthalmology
Code: 207W00000X
71535(MN)
CMS Specialties
PrimaryOPHTHALMOLOGY
Education
OTHER
Class of 2017
Research & Publications (15)
Ligand-independent HER2/HER3/PI3K complex is disrupted by trastuzumab and is effectively inhibited by the PI3K inhibitor GDC-0941.
PMID 19411071·Cancer Cell·2009
7-preclinical
Intra- and extracellular signaling by endothelial neuregulin-1.
PMID 17499242·Exp Cell Res·2007
8-other
Amplification of the epidermal growth factor receptor in astrocytic tumours by chromogenic in situ hybridization: association with clinicopathological features and patient survival.
PMID 16866989·Neuropathol Appl Neurobiol·2006
8-other
Signaling via ErbB2 and ErbB3 associates with resistance and epidermal growth factor receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cells.
PMID 16818711·Clin Cancer Res·2006
8-other
Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth.
PMID 16251361·Mol Biol Cell·2006
8-other
DNA topoisomerase I is a cofactor for c-Jun in the regulation of epidermal growth factor receptor expression and cancer cell proliferation.
PMID 15923621·Mol Cell Biol·2005
7-preclinical
Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells.
PMID 15735025·Cancer Res·2005
8-other
Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab.
PMID 15668283·Ann Oncol·2005
8-other
Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer.
PMID 15634652·Mol Cancer Ther·2004
7-preclinical
ErbB4 is downregulated in renal cell carcinoma--a quantitative RT-PCR and immunohistochemical analysis of the epidermal growth factor receptor family.
PMID 15360049·Acta Oncol·2004
8-other
Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients.
PMID 14614020·Clin Cancer Res·2003
4-observational
Angiopoietin-regulated recruitment of vascular smooth muscle cells by endothelial-derived heparin binding EGF-like growth factor.
PMID 12958167·FASEB J·2003
8-other
ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease.
PMID 12374672·Clin Cancer Res·2002
4-observational
Suppression of a key gene involved in chlorophyll biosynthesis by means of virus-inducing gene silencing.
PMID 12175014·Plant Mol Biol·2002
8-other
Erbb4 and its isoforms: selective regulation of growth factor responses by naturally occurring receptor variants.
PMID 11343971·Trends Cardiovasc Med·2000
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1611 ANNE ST NW
BEMIDJI, MN 56601 - Phone
- (218) 333-2020
Quick Facts
- NPI
- 1447772991
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 9
- Publications
- 15
Are you this provider?
Claim Your Profile